EN 
ES 
Join us in shining a light on APOL1-mediated kidney disease — a condition disproportionately affecting people of African, Caribbean, and Latin American ancestry. Together, we can raise awareness, support patients, and push for advancements in research and treatment.
Let’s unite to amplify patient voices and drive meaningful change.
Speakers:
-Keisha Gibson, MD, MPH: UNC Chapel Hill
-Corynne Corbett: Black Health Matters
-Barbara Harrison, MS, CGC: Harvard University
To learn more about Apolipoprotein L1 (APOL1), please visit our rare kidney disease page by clicking here.
Thank You To Our Sponsors
Platinum:
Bronze:
